Improving recovery after liver surgery in Hong Kong patients
The Impact of Fast-track Perioperative Program on the Clinical and Immunological Outcomes After Liver Resection in Hong Kong Chinese Patients: A Prospective Randomized Trial
This study tests a new recovery program for liver cancer surgery to see if it helps patients heal faster and stay in the hospital for a shorter time.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 94 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT03223818 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of a fast-track perioperative program on recovery outcomes for patients undergoing liver resection due to liver cancer. The program aims to reduce postoperative complications and hospital stay, which have historically been high in this patient population. By implementing enhanced recovery protocols, the study seeks to optimize surgical and anesthetic management, potentially leading to better patient outcomes. The research builds on previous findings from colorectal surgery, adapting successful strategies to liver surgery, where such studies have been limited.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 to 70 who are undergoing elective liver resection and have a good overall health status.
Not a fit: Patients undergoing emergency surgery or those with severe physical disabilities may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly reduce recovery time and hospital costs for liver cancer patients undergoing surgery.
How similar studies have performed: While similar fast-track programs have shown success in colorectal surgery, studies specifically focused on liver resection are limited, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All consecutive patients undergoing elective liver resection (open and laparoscopic). 2. Age of patients between 18 and 70 years. 3. Patients with American Society of Anaesthesiologists (ASA) grading I-II. 4. Patients with no severe physical disability. 5. Patients who require no assistance on the activities of daily living. 6. Informed consent available will be recruited. Exclusion Criteria: 1. Patients undergoing emergency surgery. 2. Patients who had received pre-operative portal vein embolization. 3. Patients who are expected to receive concomitant procedures other than cholecystectomy. 4. Pregnant ladies and patients who are mentally incapable of written consent will be excluded. 5. Patient who had previous history of Hepato-biliary and pancreatic surgery. 6. Patient who had chronic pain syndrome.
Where this trial is running
Hong Kong
- Department of Surgery — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Study coordinator: Ching Ning Chong
- Email: chongcn@surgery.cuhk.edu.hk
- Phone: 2632 1496
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.